readthroughSign in
CompanyPMVPNasdaqPrinceton, NJ

PMV Pharmaceuticals, Inc

PMV Pharma develops small molecule therapies targeting p53 for oncology.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 10Latest story